Registration statement; new shares or resale not read yet
On EDGAR, not explained yet
RZRAPharmaceutical preparations
Rezera’s latest filing is an S-1 from . Every Rezera filing is below, newest first.
On EDGAR, not explained yet.
Priced and listed · S-1 filed Oct 21, 2026
Latest: the 4 newest filings, key filings first. Each other tab counts its kind among the 4 most recent EDGAR filings.
Results, 8-Ks and Major or Notable filings come first, then registrations and share actions, then everything else, newest first. Routine filings are kept here unmarked; insider filings are summed up in one line.
Registration statement; new shares or resale not read yet
On EDGAR, not explained yet
| Date | Form | What it is |
|---|---|---|
| Oct 21, 2026 | S-1 | Registration for a share sale Key exhibits: Underwriting or sales agreement (EX-1.1), Warrants or notes (EX-4.2), Material contract (EX-10.1), Material contract (EX-10.4), Material contract (EX-10.5), Material contract (EX-10.6), Material contract (EX-10.8), Material contract (EX-10.9), Material contract (EX-10.10), Material contract (EX-10.11), Material contract (EX-10.12), Material contract (EX-10.13), Material contract (EX-10.14), Material contract (EX-10.15) |
No listing notices in the 8-K item 3.01 filings SEC Tracker has read.
Dates and rules are as stated in each 8-K item 3.01 filing; a blank means the filing did not state one. Read the filing for the full terms. All open notices
No trading halts for RZRA since Feb 22, 2019, when SEC Tracker began reading the Nasdaq Trader feed.
Halt times and codes from the Nasdaq Trader trade halts feed, which lists Nasdaq and other exchange halts. Filings matched by SEC Tracker from EDGAR by company and time. Not investment advice. All recent halts
From the company's own filings; each row names its source. Not investment advice.
Same SIC code (2834 Pharmaceutical preparations) and public float not reported.